Top Markets
#1 DogBull DogBull +108.33%
#2 ADO Protocol ADO Protocol +52.43%
#3 MarsCoin MarsCoin +49.06%
#4 Siacoin Siacoin +44.45%
#5 Nockchain Nockchain +22.09%
#6 Ontology Gas Ontology Gas +20.89%
#7 Apertum Apertum +19.60%
#8 Useless Coin Useless Coin +18.44%
#9 Falcon Finance Falcon Finance +17.38%
#10 UnifAI Network UnifAI Network +16.23%
Coin of the day
DogBull DogBull
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
BioAge Labs Inc. BioAge Labs Inc.

BioAge Labs Inc.

BIOA
Classement en actions #15446
BioAge Labs, Inc., a clinical-stage biopharmaceutical company, develops... BioAge Labs, Inc., a clinical-stage biopharmaceutical company, develops therapeutic product candidates for metabolic diseases. The company’s technology platform and differentiated human datasets that allows users to identify targets based on insights into molecular changes that drive aging. Its lead product candidate includes BGE-102, an orally available brain-penetrant small-molecule NLRP3 inhibitor which is in Phase 1 clinical trail for the treatment of atherosclerotic cardiovascular disease, as well as for the treatment of diabetic macular edema and geographic atrophy; and develops APJ agonists for obesity, including programs targeting both oral and parenteral administration. The company has collaboration agreement with Novartis Pharma AG to identify and validate novel therapeutic drug targets by investigating the biological mechanisms that drive diseases related to aging and mediate. BioAge Labs, Inc. was incorporated in 2015 and is headquartered in Emeryville, California.
Prix de l'action
$9.42
Capitalisation boursière
$354.69M
Changement (1 jour)
-0.83%
Changement (1 an)
91.09%
Pays
US
Échange BioAge Labs Inc. (BIOA)

Catégorie

Healthcare
Revenus pour BioAge Labs Inc. (BIOA)
Revenus en Sep 2026 TTM : 0
Selon les derniers rapports financiers de BioAge Labs Inc., le chiffre d'affaires actuel de l'entreprise (TTM) est de 0. En 2026, l'entreprise a réalisé un chiffre d'affaires de 0 égal à le chiffre d'affaires de l'année 2026, qui était de 0. Le chiffre d'affaires correspond au revenu total généré par la vente de biens ou de services. Contrairement au bénéfice, aucune dépense n'est déduite.
Historique des revenus pour BioAge Labs Inc. de 2026 à 2026
Revenus à la fin de chaque année
Année Revenus Changez
Pas assez de données pour les dates fournies.
Revenus d’entreprises similaires ou concurrentes
Entreprise Revenus Différence de revenus Pays
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.74B -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $2.23B -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH